Louisiana State Employees Retirement System Acquires New Position in Bath & Body Works, Inc. $BBWI

Louisiana State Employees Retirement System bought a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the first quarter, according to its most recent filing with the SEC. The firm bought 59,400 shares of the company’s stock, valued at approximately $1,109,000.

Other large investors also recently bought and sold shares of the company. Chase Investment Counsel Corp acquired a new stake in shares of Bath & Body Works during the fourth quarter worth $1,606,000. SG Americas Securities LLC grew its holdings in shares of Bath & Body Works by 725.3% during the fourth quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock valued at $9,364,000 after buying an additional 409,831 shares during the last quarter. Wedge Capital Management L L P NC increased its position in shares of Bath & Body Works by 49.9% in the 4th quarter. Wedge Capital Management L L P NC now owns 214,362 shares of the company’s stock valued at $4,304,000 after acquiring an additional 71,349 shares during the period. Vaughan Nelson Investment Management L.P. increased its position in shares of Bath & Body Works by 27.4% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 2,132,245 shares of the company’s stock valued at $42,815,000 after acquiring an additional 458,620 shares during the period. Finally, Intech Investment Management LLC increased its position in shares of Bath & Body Works by 462.6% in the 4th quarter. Intech Investment Management LLC now owns 108,766 shares of the company’s stock valued at $2,184,000 after acquiring an additional 89,432 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Down 0.0%

Shares of BBWI stock opened at $21.95 on Friday. Bath & Body Works, Inc. has a 52-week low of $14.27 and a 52-week high of $33.96. The stock has a market cap of $4.42 billion, a PE ratio of 6.17, a price-to-earnings-growth ratio of 2.18 and a beta of 1.38. The business has a 50-day simple moving average of $19.42 and a 200-day simple moving average of $20.39.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same period last year, the company earned $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts anticipate that Bath & Body Works, Inc. will post 2.62 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.6%. Bath & Body Works’s dividend payout ratio (DPR) is presently 22.47%.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Weiss Ratings cut Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, June 2nd. Piper Sandler began coverage on Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price objective on the stock. Barclays reduced their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research note on Thursday, May 28th. Telsey Advisory Group decreased their target price on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a report on Thursday, May 28th. Finally, UBS Group decreased their target price on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Bath & Body Works presently has an average rating of “Hold” and a consensus target price of $22.00.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.